Anti-Dopamine Receptor D2L (DRD2L), Titer

Optimal result: 2000 – 8000 titer

An elevated Anti-Dopamine Receptor D2L (DRD2L) titer suggests the immune system is producing antibodies that may be interfering with D2L dopamine receptor function. High titers are often associated with immune-triggered neuropsychiatric symptoms, including tics, OCD behaviors, emotional swings, agitation, impulsivity, or movement abnormalities.
A high DRD2L level may signal an active or recent immune response—often following infections such as strep, mycoplasma, or other triggers. Interpretation is strongest when combined with the full Autoimmune Brain Panel™, particularly CaMKII activity and other neuronal autoantibodies.

A low or normal DRD2L titer indicates no significant autoantibody activity against the D2L dopamine receptor. This means there is no current evidence of immune targeting of this receptor. However, neuro-immune symptoms may still arise from other mechanisms, which is why the entire panel—DRD1, anti-tubulin, anti-lysoganglioside GM1, and CaMKII—is typically reviewed together.

Anti-Dopamine Receptor D2L (DRD2L) antibodies are immune proteins that target the D2L dopamine receptor, which plays a major role in movement control, emotional regulation, reward pathways, and cognitive function. Elevated titers may suggest a neuro-immune reaction, often seen in conditions such as PANS, PANDAS, Sydenham chorea, or other autoimmune processes that affect the brain. This test helps identify whether the immune system is interacting abnormally with D2L receptors.

The Anti-Dopamine Receptor D2L (DRD2L) test measures autoantibodies directed against the D2 “long isoform” dopamine receptor, one of the most important dopamine receptors in the brain. D2L receptors are heavily involved in motor control, reward and motivation circuits, emotional regulation, executive function, and the modulation of neurotransmitter release.

When the immune system produces antibodies against D2L receptors, it may interfere with normal dopamine signaling. This process has been associated with immune-mediated neuroinflammation, particularly in children and adolescents experiencing sudden or severe neuropsychiatric symptoms. Elevated DRD2L titers have been observed in conditions such as PANS (Pediatric Acute-Onset Neuropsychiatric Syndrome), PANDAS, Sydenham chorea, and other post-infectious or autoimmune neurological disorders.

The D2L receptor is especially significant because abnormalities in D2 signaling have been linked to tics, compulsions, emotional lability, agitation, mood instability, and movement disorders. When antibodies bind to these receptors, they may disrupt dopamine’s ability to regulate neural pathways, contributing to these symptoms.

This marker is part of the Autoimmune Brain Panel™, a specialized neuro-immune test designed to assess whether autoimmune activity may be affecting neuronal structures. While DRD2L antibodies alone do not diagnose any condition, they provide important supporting evidence when evaluated alongside symptoms, infection history, other neuronal autoantibodies (DRD1, anti-tubulin, anti-lysoganglioside GM1), and CaMKII activation levels.

Anti-Dopamine Receptor D2L (DRD2L), Titer
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Anti-Dopamine Receptor D2L (DRD2L), Titer — 10,000+ markers explained
One Anti-Dopamine Receptor D2L (DRD2L), Titer result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro